Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis-Reference-Cited by-同舟云学术

Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis

Published:2013-09 Issue:2 Volume:443 Page:278-284
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Barnard Richard J.O.,McHale Carolyn M.,Newhard William,Cheney Carol A.,Graham Donald J.,Himmelberger Amy L.,Strizki Julie,Hwang Peggy M.T.,Rivera Amber A.,Reeves Jacqueline D.,Nickle David,DiNubile Mark J.,Hazuda Daria J.,Mobashery Niloufar

Publisher

Elsevier BV

Subject

Virology

Reference22 articles.

1. Futility rules for telaprevir combination treatment for patients with hepatitis C virus infection;Adda;Clin. Gastroenterol. Hepatol,2013

2. Boceprevir for previously treated chronic HCV genotype 1 infection;Bacon;N. Engl. J. Med.,2011

3. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment;Bartels;J. Virol.,2013

4. HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors;Cento;PLoS One,2012

5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N. Engl. J. Med.,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. World-wide Prevalence of Substitutions in HCV Genome Associated With Resistance to Direct-Acting Antiviral Agents;Clinical Gastroenterology and Hepatology;2021-09

2. Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure;Infection;2018-08-06

3. Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018;Drug Resistance Updates;2018-03

4. Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection;Comprehensive Medicinal Chemistry III;2017

5. Hepatitis C virus resistance to the new direct-acting antivirals;Expert Opinion on Drug Metabolism & Toxicology;2016-07-18